Results 11 to 20 of about 178,855,135 (215)
Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis [PDF]
Case Reports in Oncological Medicine, 2014 Osteonecrosis of the jaw is usually a potential complication of bisphosphonate therapy. In a cancer patient, this disease entity can be misdiagnosed as a metastatic lesion. Our aim is to make clinicians aware of bisphosphonate associated osteonecrosis of
Geetika Bhatt +4 more
doaj +2 more sources
Haematologica, 2011 Osteonecrosis of the jaw is an uncommon but potentially serious complication of bisphosphonate therapy in multiple myeloma. Previous studies showed that the presence of one or two minor alleles of the cytochrome P450, subfamily 2C polypeptide 8 gene ...
Esperanza Such +13 more
doaj +3 more sources
Clinical Interventions in Aging, 2014 Licia Manzon,1 Evaristo Ettorre,1 Giovanni Viscogliosi,1 Stefano Ippoliti,1 Fabio Filiaci,2 Claudio Ungari,2 Giovanni Fratto,1 Alessandro Agrillo2 1Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences ...
Manzon L +7 more
doaj +1 more source
Bisphosphonate Related Osteonecrosis of the Jaw: A Study of 18 Cases Associated with Fungal Infection [PDF]
International Journal of Dentistry, 2014 Osteonecrosis of the jaw (ONJ) is a serious complication associated with oral and intravenous bisphosphonate therapy. Its pathogenesis is not well understood and its management is difficult.
V. Aftimos +3 more
doaj +2 more sources
Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw [PDF]
Oral and Maxillofacial Surgery Clinics of North America, 2015 Osteonecrosis of the jaws (ONJ) is a potentially severe disorder that develops in a subgroup of individuals who have used bisphosphonate (BP) medications. Several clinical risk factors have been associated with the risk of ONJ development, but evidence is limited and in most instances ONJ remains an unpredictable adverse drug reaction.
Fung, PL +4 more
openaire +3 more sources
Communications Medicine, 2022 Okawa et al. evaluate a fluorescent risedronate analogue, 800CW-pRIS, as a potential treatment for medication-related osteonecrosis of the jaw. The authors demonstrate an improvement in wound healing and inflammation with 800CW-pRIS pre-treatment in a ...
Hiroko Okawa +11 more
doaj +1 more source
Annali di Stomatologia, 2021 Bisphosphonate related osteonecrosis of the jaw (BRONJ) can occur in patients affected by malignancy associated hypercalcemia, bone metastases of solid tumors or multiple myeloma intaking amino-bisphosphonates or other bone resorption inhibitors.
A. Massaria +3 more
doaj +1 more source
Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)
European Journal of Case Reports in Internal Medicine, 2019 Introduction: Osteonecrosis of the jaw has been consistently reported in the literature associated to the high-dose intravenous bisphosphonate therapy. However, osteonecrosis can also occur in patients who have other risk factors.
Simone Marconcini +4 more
doaj +1 more source
Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review
eJournal of Oral Maxillofacial Research, 2018 Objectives: The review aims to study dental implant placement purposefulness for patients who have been treated or are on treatment with bisphosphonate medication.
Rokas Gelazius +4 more
doaj +1 more source
Guidelines for bisphosphonate-associated osteonecrosis of the jaw [PDF]
Evidence-Based Dentistry, 2008 This guideline aimed to provide recommendations for the diagnosis of bisphosphonate-associated osteonecrosis of the jaw in both the oncology and osteoporosis patient populations, for dental and medical practitioners including dentists, oral surgeons, oral pathologists, general practitioners and internal medicine specialists.
openaire +2 more sources